Censis Technologies and Cantel Medical Enter into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution
Companies combining their key strengths to provide enhanced integrated workflow software solution designed to provide superior infection prevention and practice optimization
December 7, 2020, Franklin, TN – Today, Censis Technologies, a wholly-owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantel’s leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.
The new enhanced, co-branded software solution will combine the CANEXIS™ Integrated Workflow Solution for Endoscopy from Cantel with Censis’ CensiTrac™ surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market.
Leveraging Censis’ strengths in software development, cloud-based technology, and professional services and support with the leading position in endoscope reprocessing and infection prevention from Cantel, the combined solution will support endoscopy customers with best-in-class quality management tools, providing peace of mind and confidence that their facility is executing best practices to support patient safety and infection prevention.
This enhanced integrated workflow solution is a key tool in the fight to avoid the spread of infection while helping to protect patients and reducing the economic burden on facilities, while also supporting improved efficiency and understanding of the use of critical medical devices in healthcare facilities. In today’s environment, efficiency and process consistency are increasingly critical to the day-to-day and long-term success of infection prevention, and this software application is an important resource for helping to ensure a consistent repeatable standard of care and process at each facility.
Healthcare-associated infections (HAIs) are a complex and persistent issue in healthcare facilities. Each year, approximately 1.7 million HAIs occur, and outbreaks also pose a severe economic burden to the health system, with the total direct, indirect, and nonmedical social costs of HAIs to hospitals ranging from US$96 billion to $147 billion.
Randy Smith, CEO, Censis Technologies said, “The relationship with Cantel will expand Censis’ leadership in surgical asset management and tracking solutions by further introducing innovative SaaS-based technology for the reprocessing of endoscopes. We are excited that the combined efforts of these two organizations will provide our customers with opportunities to improve patient safety, workflow optimization, and analytics.”
“We are thrilled to be partnering with Censis on this critical endeavor,” said Michael Spicer, President, Medical Business Unit at Cantel. “At Cantel, we strive to ensure our Complete Circle of Protection includes best-in-class offerings for our customers and patients, and by partnering with Censis, we are taking the next step toward providing greater efficiency, protection, and analytics to allow our customers to maximize their practice workflow while providing solutions designed to improve the safety and protection of their patients.”
Within the United States, users of the current CANEXIS™ Software can look forward to robust coverage, including implementation, upgrades, and technical support, as their service is enhanced through the co-brand partnership.
ABOUT CENSIS TECHNOLOGIES
Censis Technologies, based in Franklin, Tennessee, is the leader in surgical instrument and asset management software. Censis offers a range of solutions, including CensiTrac®, which is a highly advanced, web-based software system focused on maximizing OR throughput and regulatory compliance. Censis Technologies’ software is deployed in over 1000 hospitals in the United States, Canada, and Australia.
For more information please visit www.censis.com.
Fortive is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. The company holds leading positions in intelligent operating solutions, precision technologies, and advanced healthcare solutions. Fortive is headquartered in Everett, Washington, and employs a team of more than 17,000 research and development, manufacturing, sales, distribution, service, and administrative employees in more than 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System.
For more information please visit www.fortive.com.
ABOUT CANTEL MEDICAL
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For more information visit www.cantelmedical.com.
Download the Transition from a Manual Process to Automated [eBook] Now!